This decrease in blood calcium levels among MHD patients could be attributed to various factors, including vitamin D deficiency, hypothyroidism, and the usage of calcium-containing phosphorus binders, vitamin D receptor agonists, and calcium-sensitive receptor agonists. This evidence concerns the gene VDR and hypothyroidism.